Amphastar Pharmaceuticals reported quarterly EPS of $0.42, well below the Zacks Consensus Estimate of $0.70 and down from $0.74 a year ago. The earnings miss is a clear negative for near-term sentiment, though the article provides no revenue, guidance, or other operational details.
Amphastar Pharmaceuticals reported quarterly EPS of $0.42, well below the Zacks Consensus Estimate of $0.70 and down from $0.74 a year ago. The earnings miss is a clear negative for near-term sentiment, though the article provides no revenue, guidance, or other operational details.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.35
Ticker Sentiment
